Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-04

Clinical Trial Update: Exparel in Minimally Invasive Cardiac Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Exparel in minimally invasive cardiac surgery was terminated; results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: Maimonides Medical Center | Conditions: Cardiac Disease | Phase 4 | Status: TERMINATED | Results posted: 2019-10-04